162 related articles for article (PubMed ID: 34782322)
1. mTOR-Dependent ARID1A Degradation: A New Twist in the Genetic-Epigenetic Interplay Driving Hepatocellular Carcinoma.
Pease DR; Fernandez-Zapico ME
Cancer Res; 2021 Nov; 81(22):5608-5610. PubMed ID: 34782322
[TBL] [Abstract][Full Text] [Related]
2. mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.
Zhang S; Zhou YF; Cao J; Burley SK; Wang HY; Zheng XFS
Cancer Res; 2021 Nov; 81(22):5652-5665. PubMed ID: 34429326
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway.
Guo M; Li N; Zheng J; Wang W; Wu Y; Han X; Guo J; Chen W; Bai Z; Bai W; Wu J
Can J Gastroenterol Hepatol; 2021; 2021():5596712. PubMed ID: 34123955
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic deregulation of microRNAs: new opportunities to target oncogenic signaling pathways in hepatocellular carcinoma.
Yu Z; Cheng AS
Curr Pharm Des; 2013; 19(7):1192-200. PubMed ID: 23092339
[TBL] [Abstract][Full Text] [Related]
5. ARID2 Chromatin Remodeler in Hepatocellular Carcinoma.
Loesch R; Chenane L; Colnot S
Cells; 2020 Sep; 9(10):. PubMed ID: 32977645
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma.
Kanda M; Sugimoto H; Kodera Y
World J Gastroenterol; 2015 Oct; 21(37):10584-97. PubMed ID: 26457018
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Epigenetic Alterations in Human Hepatocellular Carcinoma and Its Association with Genetic Mutations.
Nishida N; Kudo M
Dig Dis; 2016; 34(6):708-713. PubMed ID: 27750242
[TBL] [Abstract][Full Text] [Related]
8. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma.
Wu Y; Zhang Y; Qin X; Geng H; Zuo D; Zhao Q
Pharmacol Res; 2020 Oct; 160():105195. PubMed ID: 32916254
[TBL] [Abstract][Full Text] [Related]
9. Significance and mechanism of androgen receptor overexpression and androgen receptor/mechanistic target of rapamycin cross-talk in hepatocellular carcinoma.
Zhang H; Li XX; Yang Y; Zhang Y; Wang HY; Zheng XFS
Hepatology; 2018 Jun; 67(6):2271-2286. PubMed ID: 29220539
[TBL] [Abstract][Full Text] [Related]
10. Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma.
Ribback S; Che L; Pilo MG; Cigliano A; Latte G; Pes GM; Porcu A; Pascale RM; Li L; Qiao Y; Dombrowski F; Chen X; Calvisi DF
Cell Cycle; 2018; 17(12):1496-1512. PubMed ID: 29965794
[TBL] [Abstract][Full Text] [Related]
11. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma.
Rahmani F; Ziaeemehr A; Shahidsales S; Gharib M; Khazaei M; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
J Cell Physiol; 2020 May; 235(5):4146-4152. PubMed ID: 31663122
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets.
Bayo J; Fiore EJ; Dominguez LM; Real A; Malvicini M; Rizzo M; Atorrasagasti C; GarcĂa MG; Argemi J; Martinez ED; Mazzolini GD
J Hepatol; 2019 Jul; 71(1):78-90. PubMed ID: 30880225
[TBL] [Abstract][Full Text] [Related]
14. mTOR in viral hepatitis and hepatocellular carcinoma: function and treatment.
Wang Z; Jin W; Jin H; Wang X
Biomed Res Int; 2014; 2014():735672. PubMed ID: 24804240
[TBL] [Abstract][Full Text] [Related]
15. Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.
Sun X; Wang SC; Wei Y; Luo X; Jia Y; Li L; Gopal P; Zhu M; Nassour I; Chuang JC; Maples T; Celen C; Nguyen LH; Wu L; Fu S; Li W; Hui L; Tian F; Ji Y; Zhang S; Sorouri M; Hwang TH; Letzig L; James L; Wang Z; Yopp AC; Singal AG; Zhu H
Cancer Cell; 2017 Nov; 32(5):574-589.e6. PubMed ID: 29136504
[TBL] [Abstract][Full Text] [Related]
16. The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma.
Pollutri D; Patrizi C; Marinelli S; Giovannini C; Trombetta E; Giannone FA; Baldassarre M; Quarta S; Vandewynckel YP; Vandierendonck A; Van Vlierberghe H; Porretti L; Negrini M; Bolondi L; Gramantieri L; Fornari F
Cell Death Dis; 2018 Jan; 9(1):4. PubMed ID: 29305580
[TBL] [Abstract][Full Text] [Related]
17. Cinobufagin Triggers Defects in Spindle Formation and Cap-Dependent Translation in Liver Cancer Cells by Inhibiting the AURKA-mTOR-eIF4E Axis.
Jin X; Wang J; Zou S; Xu R; Cao J; Zhang Y; Guo J; Wen X; Deng S; Zheng Y; Zhu Y; Wang F; Xu Z
Am J Chin Med; 2020; 48(3):651-678. PubMed ID: 32349518
[TBL] [Abstract][Full Text] [Related]
18. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.
Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D
World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871
[TBL] [Abstract][Full Text] [Related]
19.
Ho DWH; Chan LK; Chiu YT; Xu IMJ; Poon RTP; Cheung TT; Tang CN; Tang VWL; Lo ILO; Lam PWY; Yau DTW; Li MX; Wong CM; Ng IOL
Gut; 2017 Aug; 66(8):1496-1506. PubMed ID: 27974549
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation in hepatocellular carcinoma.
Tischoff I; Tannapfe A
World J Gastroenterol; 2008 Mar; 14(11):1741-8. PubMed ID: 18350605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]